Reuters logo
3 months ago
BRIEF-Array Biopharma & Ono Pharmaceutical announce partnership for two Novel Oncology compounds
May 31, 2017 / 7:18 AM / 3 months ago

BRIEF-Array Biopharma & Ono Pharmaceutical announce partnership for two Novel Oncology compounds

May 31 (Reuters) - Array Biopharma Inc

* Array Biopharma & Ono Pharmaceutical Co Ltd announce license, development & commercialization partnership for 2 Novel Oncology compounds, Binimetinib and Encorafenib

* Array Biopharma says Array to receive $31.6 million up-front payment and up to $156.0 million in additional development and commercial milestones

* Ono will receive rights to develop and commercialize Binimetinib and Encorafenib in Japan and South Korea Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below